"At New Jersey Urology (NJU), our experienced team of award-winning, top urologists and clinical support professionals are dedicated to improving the health of our patients. As the largest urology practice in the country, we specialize in all areas of urological health and offer comprehensive treatment options, in-house laboratory testing and six state-of-the-art cancer treatment centers."

During the past decade, New Jersey Urology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Jersey Urology" #1 sponsor was "MedtronicNeuro" with 2 trials, followed by "UroGen Pharma Ltd." with 2 trials sponsored, "Urovant Sciences GmbH" with 2 trials sponsored, "Axonics Modulation Technologies, Inc." with 1 trials sponsored and "Urotronic Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Jersey Urology" #1 collaborator was "ClinLogix. LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "New Jersey Urology" are "Overactive Bladder" (4 trials), "Bladder Cancer" (2 trials), "Urinary Urge Incontinence" (2 trials), "Urothelial Carcinoma" (2 trials) and "Urothelial Carcinoma Bladder" (2 trials). Many other conditions were trialed in "New Jersey Urology" in a lesser frequency.

Most popular intervention types in "New Jersey Urology" are "Drug" (4 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "UGN-102" (2 trials), "Vibegron" (2 trials), "InterStim Basic Evaluation lead and foramen needle" (1 trials), "Medtronic Implantable Tibial Neuromodulation (TNM) System" (1 trials) and "Optilume BPH Catheter System" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Jersey Urology" are 5 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "New Jersey Urology". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in New Jersey Urology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New Jersey Urology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".